Myofascial Pain SyndromeNCT06018675
Comparison of Kinesio Taping, Dry Needling and Lidocain Injection Methods in Myofascial Pain Syndrome
An observational study of Myofascial Pain Syndrome, run by Bursa City Hospital.
Trial summary
Myofascial pain syndrome (MPS) is a chronic pain syndrome characterized by the presence of trigger points in muscles and fascia in various parts of the body. Due to the pain, it has negative effects on function, restricting movements and daily life activities. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Myofascial Pain Syndrome
- What is being tested?
- kinesiotherapy
- Type of treatment
- Injection or infusion
- How many people
- 66 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2017to 1 Aug 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All patients between 18-70 years who were diagnosed with myofascial pain syndrome in the upper trapezius muscle between January 2017 to December 2018 at our institution were enrolled in this study. According to the power analysis result, 22 patients files were randomly selected among the patients received KT (group 1) using the coin method, and 22 files were randomly selected from the files of patients receiving dry needling (group 2) and lidocaine injection (group 3) treatment in the same way.
Who may be able to join
- Beetween the age of 18-70
- Presence of myofascial pain syndrome in the upper trapezius muscle
Who cannot join
- Received conventional physical therapy in the last 6 months
- Diagnosed with fibromyalgia or fibromyalgia treatment
- History of neurological disease, malignancy, cervical disc hernia
- Undergone surgical intervention in the shoulder or neck region
- Received treatment for the diagnosis of myofascial pain syndrome in the last year
About this study
Myofascial pain syndrome (MPS) is a chronic pain syndrome characterized by the presence of trigger points in muscles and fascia in various parts of the body. Due to the pain, it has negative effects on function, restricting movements and daily life activities. Several invasive and non-invasive methods with proven effectiveness are described in the management of myofascial pain syndrome. In this study, investigators aimed to compare the effect of kinesiotaping with dry needling and lidocaine injection treatment. İnvestigators hypothesized, that the effect of kinesiotaping have similar results compared to the invasiv treatment methods in the treatment of MPS.
Sixty-six patients diagnosed with myofascial pain syndrome in the upper trapezius were included in this retrospective study. Patients were divided into three groups. Twenty-two patients were randomly selected among patients who received kinesiotaping treatment (n:22). Twenty-two patients who received dry needling treatment (group 2) and 22 patients who received lidocaine injection treatment were randomly selected as controls. Patients were evaluated using the Visual Analogue Scale (VAS) and the Short Form (SF-36) scales, which were completed before and 3 weeks after the treatment.
Read the detailed description
Myofascial pain syndrome (MPS) is a chronic pain syndrome characterized by the presence of trigger points in muscles and fascia in various parts of the body. Myofascial pain syndrome is one of the most common musculoskeletal problems in adults, and its prevalence varies between 30-93%. Patients have symptoms such as pain (local or referred), loss of muscle strength, stiffness, and restriction of range of motion. Although the etiology of myofascial pain syndrome is not well understood, causes such as posture disorder, trauma, and ergonomic problems appear as etiology. Simon criteria are often used in the diagnosis. Apart from this, anamnesis and detailed physical examination are important in the diagnosis of MPS.
Dry needling is a treatment method which uses needles similar to those used in acupuncture, without any injectable drug to myofascial trigger points. Dry needling shows its effect through the exposure to various chemical mediators. The observation of a local course response in dry needling shows that the treatment is effective. Side effects such as bleeding, localized pain, vasovagal syncope, and rarely pneumothorax may occur during the treatment of dry needling.
Lidocaine injection and Dry needling are different applications that injectable drugs are not use in dry needling. Lidocain injection applied by giving a local anesthetic substance on the trigger point. It has been reported in the conducted studies that it has a similar effect as dry needling and that local pain is less common after injection.
Kinesiotaping (KT) is a treatment method developed by Dr. Kenzo Kase, which has been initially applied in the treatment of pain, and its use has become widespread in recent years. KT tape is a thin and flexible tape that allows joint movements. KT tape is widely used in the treatment of pain relief, muscle relaxation, edema reducement, improvement of muscle strength, and posture correction. Although the exact mechanism of KT is not well known, it is believed to cause a decrease in nociceptor pressure, create a space in the subcutaneous area, convenience in the removal of chemical mediators from the tissue, and also stimulation of somotosensory and proprioceptive mechanisms.
In our study, investigators aimed to compare the effectiveness of non-invasive KT on myofascial pain syndrome treatment with invasive treatment methods such as dry needling and lidocaine injections. The investigators hypothesized, that the effect of kinesiotherapy have similar results compared to the invasiv treatment methods in the management of MPS.
After IRB approval and informed consent by all patients were obtained, investigators performed this retrospective study. Instutional review board was obtained by the ethics committee of Bağcılar Training and Research Hospital (Number: 018.07.2.03.057.r1.071). All patients between 18-70 years who were diagnosed with myofascial pain syndrome in the upper trapezius muscle between January 2017 to December 2018 at investigator 's institution were enrolled in this study. According to the power analysis result, 22 patients files were randomly selected among the patients received KT (group 1) using the coin method, and 22 files were randomly selected from the files of patients receiving dry needling (group 2) and lidocaine injection (group 3) treatment in the same way. There were no differences between the age and gender distributions of all 3 selected groups. Patients, who have received conventional physical therapy in the last 6 months, diagnosed with fibromyalgia or fibromyalgia treatment, with a history of neurological disease, malignancy, cervical disc hernia, and who have undergone surgical intervention in the shoulder or neck region or who have received treatment for the diagnosis of myofascial pain syndrome in the last year were excluded from our study.
All 3 treatment modalities were applied to the patients by the same physician. KT treatment was performed using the pain inhibition technique for KT treatment recipients in group 1 (n=22). A total of 3 sessions, one week apart, were applied to the patients using the application of KinesioTex Gold Band. Patients received the treatment in a sitting position. The application was performed while the patients were in the sitting position with the neck in lateral flexion and rotation to the contralateral side. Two 15 cm and 20 cm bands were used in the application, respectively. The first band origin was adhered to the acromion, maximum tension was applied to the first 5-6 cm of tape. Tension was not applied to the rest of the band. The second band was cut in a Y-shape. The application's origin was acromion. The upper part of the Y legs of the tape was applied to the C7 spinosus process and the lower part was applied to the T12 region. Maximum stress was applied to both ends of the tape.
The patients in group 2 who underwent dry needling were applied with 0.25x25 mm sterile acupuncture needles after cleaning the skin with alcohol while in a sitting position. The pistoning was performed on the trigger points in a radial manner and until the local twitch response was obtained. The needles were left in the pistoning area for another 10 minutes after the twitch response was obtained.
The pistoning was made to the patients in Group 3, sitting in an upright position. 2% lidocaine was injected with 26 Gauchl 0.45x13 mm disposable sterile needles into 3 trigger points where the pain was most felt, after sterilizing the skin with a local antiseptic.
All three groups underwent trapeze stretching exercises and were not given any medical treatment.
All patients were evaluated with VAS and SF-36 form before and 3 weeks after treatment. The VAS scale is a pain scale with marked 0-10 areas. Zero represents the absence of pain, while 10 represents very severe pain. The SF-36 form consists of 36 items to evaluate the daily life activities of the patients. It is used to evaluate many daily life functions such as general health status, physical condition, social status, emotional state. A high SF-36 score is one of the indicators of well-being in health.
- Conditions
- Myofascial Pain Syndrome
- Being tested
- kinesiotherapy
- Keywords
- myofascial pain syndrome, dry needling, kinesiotherapy, lidocain injection, quality of life
- Medical subject headings
- Myofascial Pain Syndromes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
kinesiotherapyOther
Also called dry needling, lidocain injection
Group 1: Kinesiotherapy Group 2: Dry needling Group 3: lidocain injection
| Study group | Role | What they receive |
|---|---|---|
| Group 1 | Kinesiotherapy Receives: Other: kinesiotherapy | |
| Group 2 | Dry needling | |
| Group 3 | Lidocain injection |
What is being measured
The primary outcome is the main question the study is designed to answer.
Visual Analog Scala (VAS)
The VAS scale is a pain scale with marked 0-10 areas. Zero represents the absence of pain, while 10 represents very severe pain.
Measured: All patients were evaluated with VAS and SF-36 form before and 3 weeks after treatment.
Short form-36 (SF-36)
The SF-36 form consists of 36 items to evaluate the daily life activities of the patients. It is used to evaluate many daily life functions such as general health status, physical condition, social status, emotional state. A high SF-36 score is one of the indicators of well-being in health.
Measured: All patients were evaluated with VAS and SF-36 form before and 3 weeks after treatment.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Aug 2023
- Study start1 Jan 2017
- Primary completion1 Jan 2019
- Study completion1 Aug 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (14)Papers the sponsor has linked to this study.
- Other trials for Myofascial Pain SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 66 participants (actual)
Sponsor and investigators
- Lead sponsor
- Bursa City Hospital
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Sezin Solum, Bursa City Hospital
- Investigators
- Seher Kara, MD, Study director, Gaziosmapaşa Training and Research Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06018675
- Sponsor's protocol ID
- 9999999993
- Status last verified
- Aug 2023
- First submitted
- 22 Aug 2023
- Last updated
- 31 Aug 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Dogan N, Sengul I, Akcay-Yalbuzdag S, Kaya T. Kinesio taping versus dry needling in the treatment of myofascial pain of the upper trapezius muscle: A randomized, single blind (evaluator), prospective study. J Back Musculoskelet Rehabil. 2019;32(5):819-827. doi: 10.3233/BMR-181162.
PubMed 30883331Ay S, Konak HE, Evcik D, Kibar S. The effectiveness of Kinesio Taping on pain and disability in cervical myofascial pain syndrome. Rev Bras Reumatol Engl Ed. 2017 Mar-Apr;57(2):93-99. doi: 10.1016/j.rbre.2016.03.012. Epub 2016 May 10. English, Portuguese.
PubMed 28343625Albagieh H, Aloyouny A, Alshehri N, Alsammahi N, Almutrafi D, Hadlaq E. Efficacy of lidocaine versus mepivacaine in the management of myofascial pain. Saudi Pharm J. 2020 Oct;28(10):1238-1242. doi: 10.1016/j.jsps.2020.08.014. Epub 2020 Aug 28.
PubMed 33132718Raeissadat SA, Rayegani SM, Sadeghi F, Rahimi-Dehgolan S. Comparison of ozone and lidocaine injection efficacy vs dry needling in myofascial pain syndrome patients. J Pain Res. 2018 Jun 29;11:1273-1279. doi: 10.2147/JPR.S164629. eCollection 2018.
PubMed 29988746Kalichman L, Vulfsons S. Dry needling in the management of musculoskeletal pain. J Am Board Fam Med. 2010 Sep-Oct;23(5):640-6. doi: 10.3122/jabfm.2010.05.090296.
PubMed 20823359Gerber LH, Shah J, Rosenberger W, Armstrong K, Turo D, Otto P, Heimur J, Thaker N, Sikdar S. Dry Needling Alters Trigger Points in the Upper Trapezius Muscle and Reduces Pain in Subjects With Chronic Myofascial Pain. PM R. 2015 Jul;7(7):711-718. doi: 10.1016/j.pmrj.2015.01.020. Epub 2015 Feb 4.
PubMed 25661462Ghasemi M, Mosaffa F, Hoseini B, Behnaz F. Comparison of the Effect of Bicarbonate, Hyaluronidase, and Lidocaine Injection on Myofascial Pain Syndrome. Anesth Pain Med. 2020 Jun 23;10(3):e101037. doi: 10.5812/aapm.101037. eCollection 2020 Jun.
PubMed 32944559Fricton J. Myofascial Pain: Mechanisms to Management. Oral Maxillofac Surg Clin North Am. 2016 Aug;28(3):289-311. doi: 10.1016/j.coms.2016.03.010.
PubMed 27475508Shah JP, Thaker N, Heimur J, Aredo JV, Sikdar S, Gerber L. Myofascial Trigger Points Then and Now: A Historical and Scientific Perspective. PM R. 2015 Jul;7(7):746-761. doi: 10.1016/j.pmrj.2015.01.024. Epub 2015 Feb 24.
PubMed 25724849Fleckenstein J, Zaps D, Ruger LJ, Lehmeyer L, Freiberg F, Lang PM, Irnich D. Discrepancy between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: results of a cross-sectional, nationwide survey. BMC Musculoskelet Disord. 2010 Feb 11;11:32. doi: 10.1186/1471-2474-11-32.
PubMed 20149248Onat SS, Polat CS, Bicer S, Sahin Z, Tasoglu O. Effect of Dry Needling Injection and Kinesiotaping on Pain and Quality of Life in Patients with Mechanical Neck Pain. Pain Physician. 2019 Nov;22(6):583-589.
PubMed 31775405Ozturk G, Kulcu DG, Mesci N, Silte AD, Aydog E. Efficacy of kinesio tape application on pain and muscle strength in patients with myofascial pain syndrome: a placebo-controlled trial. J Phys Ther Sci. 2016 Apr;28(4):1074-9. doi: 10.1589/jpts.28.1074. Epub 2016 Apr 28.
PubMed 27190430Yilmaz N, Erdal A, Demir O. A comparison of dry needling and kinesiotaping therapies in myofascial pain syndrome: A randomized clinical study. Turk J Phys Med Rehabil. 2020 Aug 18;66(3):351-359. doi: 10.5606/tftrd.2020.3917. eCollection 2020 Sep.
PubMed 33089092Noguera-Iturbe Y, Martinez-Gramage J, Montanez-Aguilera FJ, Casana J, Lison JF. Short-Term Effects of Kinesio Taping in the Treatment of Latent and Active Upper Trapezius Trigger Points: two Prospective, Randomized, Sham-Controlled Trials. Sci Rep. 2019 Oct 9;9(1):14478. doi: 10.1038/s41598-019-51146-4.
PubMed 31597934
Study at a glance
From the registry record, last updated by the sponsor on 31 Aug 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Kinesio Taping, Dry Needling and Lidocain Injection Methods in Myofascial Pain Syndrome
- ClinicalTrials.gov ID
- NCT06018675
- Acronym / sponsor ID
- 9999999993
- Conditions
- Myofascial Pain Syndrome
- Keywords
- myofascial pain syndrome, dry needling, kinesiotherapy, lidocain injection, quality of life
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 66 participants (actual)
- Lead sponsor
- Bursa City HospitalOther government
- Study start
- 1 Jan 2017 (actual)
- Primary completion
- 1 Jan 2019 (actual)
- Study completion
- 1 Aug 2019 (actual)
- First posted
- 31 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Myofascial pain syndrome (MPS) is a chronic pain syndrome characterized by the presence of trigger points in muscles and fascia in various parts of the body. Due to the pain, it has negative effects on function, restricting movements and daily life activities. Several invasive and non-invasive methods with proven effectiveness are described in the management of myofascial pain syndrome. In this study, investigators aimed to compare the effect of kinesiotaping with dry needling and lidocaine injection treatment. İnvestigators hypothesized, that the effect of kinesiotaping have similar results compared to the invasiv treatment methods in the treatment of MPS.
Sixty-six patients diagnosed with myofascial pain syndrome in the upper trapezius were included in this retrospective study. Patients were divided into three groups. Twenty-two patients were randomly selected among patients who received kinesiotaping treatment (n:22). Twenty-two patients who received dry needling treatment (group 2) and 22 patients who received lidocaine injection treatment were randomly selected as controls. Patients were evaluated using the Visual Analogue Scale (VAS) and the Short Form (SF-36) scales, which were completed before and 3 weeks after the treatment.
Detailed description
Myofascial pain syndrome (MPS) is a chronic pain syndrome characterized by the presence of trigger points in muscles and fascia in various parts of the body. Myofascial pain syndrome is one of the most common musculoskeletal problems in adults, and its prevalence varies between 30-93%. Patients have symptoms such as pain (local or referred), loss of muscle strength, stiffness, and restriction of range of motion. Although the etiology of myofascial pain syndrome is not well understood, causes such as posture disorder, trauma, and ergonomic problems appear as etiology. Simon criteria are often used in the diagnosis. Apart from this, anamnesis and detailed physical examination are important in the diagnosis of MPS.
Dry needling is a treatment method which uses needles similar to those used in acupuncture, without any injectable drug to myofascial trigger points. Dry needling shows its effect through the exposure to various chemical mediators. The observation of a local course response in dry needling shows that the treatment is effective. Side effects such as bleeding, localized pain, vasovagal syncope, and rarely pneumothorax may occur during the treatment of dry needling.
Lidocaine injection and Dry needling are different applications that injectable drugs are not use in dry needling. Lidocain injection applied by giving a local anesthetic substance on the trigger point. It has been reported in the conducted studies that it has a similar effect as dry needling and that local pain is less common after injection.
Kinesiotaping (KT) is a treatment method developed by Dr. Kenzo Kase, which has been initially applied in the treatment of pain, and its use has become widespread in recent years. KT tape is a thin and flexible tape that allows joint movements. KT tape is widely used in the treatment of pain relief, muscle relaxation, edema reducement, improvement of muscle strength, and posture correction. Although the exact mechanism of KT is not well known, it is believed to cause a decrease in nociceptor pressure, create a space in the subcutaneous area, convenience in the removal of chemical mediators from the tissue, and also stimulation of somotosensory and proprioceptive mechanisms.
In our study, investigators aimed to compare the effectiveness of non-invasive KT on myofascial pain syndrome treatment with invasive treatment methods such as dry needling and lidocaine injections. The investigators hypothesized, that the effect of kinesiotherapy have similar results compared to the invasiv treatment methods in the management of MPS.
After IRB approval and informed consent by all patients were obtained, investigators performed this retrospective study. Instutional review board was obtained by the ethics committee of Bağcılar Training and Research Hospital (Number: 018.07.2.03.057.r1.071). All patients between 18-70 years who were diagnosed with myofascial pain syndrome in the upper trapezius muscle between January 2017 to December 2018 at investigator 's institution were enrolled in this study. According to the power analysis result, 22 patients files were randomly selected among the patients received KT (group 1) using the coin method, and 22 files were randomly selected from the files of patients receiving dry needling (group 2) and lidocaine injection (group 3) treatment in the same way. There were no differences between the age and gender distributions of all 3 selected groups. Patients, who have received conventional physical therapy in the last 6 months, diagnosed with fibromyalgia or fibromyalgia treatment, with a history of neurological disease, malignancy, cervical disc hernia, and who have undergone surgical intervention in the shoulder or neck region or who have received treatment for the diagnosis of myofascial pain syndrome in the last year were excluded from our study.
All 3 treatment modalities were applied to the patients by the same physician. KT treatment was performed using the pain inhibition technique for KT treatment recipients in group 1 (n=22). A total of 3 sessions, one week apart, were applied to the patients using the application of KinesioTex Gold Band. Patients received the treatment in a sitting position. The application was performed while the patients were in the sitting position with the neck in lateral flexion and rotation to the contralateral side. Two 15 cm and 20 cm bands were used in the application, respectively. The first band origin was adhered to the acromion, maximum tension was applied to the first 5-6 cm of tape. Tension was not applied to the rest of the band. The second band was cut in a Y-shape. The application's origin was acromion. The upper part of the Y legs of the tape was applied to the C7 spinosus process and the lower part was applied to the T12 region. Maximum stress was applied to both ends of the tape.
The patients in group 2 who underwent dry needling were applied with 0.25x25 mm sterile acupuncture needles after cleaning the skin with alcohol while in a sitting position. The pistoning was performed on the trigger points in a radial manner and until the local twitch response was obtained. The needles were left in the pistoning area for another 10 minutes after the twitch response was obtained.
The pistoning was made to the patients in Group 3, sitting in an upright position. 2% lidocaine was injected with 26 Gauchl 0.45x13 mm disposable sterile needles into 3 trigger points where the pain was most felt, after sterilizing the skin with a local antiseptic.
All three groups underwent trapeze stretching exercises and were not given any medical treatment.
All patients were evaluated with VAS and SF-36 form before and 3 weeks after treatment. The VAS scale is a pain scale with marked 0-10 areas. Zero represents the absence of pain, while 10 represents very severe pain. The SF-36 form consists of 36 items to evaluate the daily life activities of the patients. It is used to evaluate many daily life functions such as general health status, physical condition, social status, emotional state. A high SF-36 score is one of the indicators of well-being in health.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Group 1 | – | Other: kinesiotherapyKinesiotherapy |
| Group 2 | – | –Dry needling |
| Group 3 | – | –Lidocain injection |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All patients between 18-70 years who were diagnosed with myofascial pain syndrome in the upper trapezius muscle between January 2017 to December 2018 at our institution were enrolled in this study. According to the power analysis result, 22 patients files were randomly selected among the patients received KT (group 1) using the coin method, and 22 files were randomly selected from the files of patients receiving dry needling (group 2) and lidocaine injection (group 3) treatment in the same way.
Key inclusion criteria (2 listed)
- Beetween the age of 18-70
- Presence of myofascial pain syndrome in the upper trapezius muscle
Key exclusion criteria (5 listed)
- Received conventional physical therapy in the last 6 months
- Diagnosed with fibromyalgia or fibromyalgia treatment
- History of neurological disease, malignancy, cervical disc hernia
- Undergone surgical intervention in the shoulder or neck region
- Received treatment for the diagnosis of myofascial pain syndrome in the last year
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| kinesiotherapyAlso: dry needling, lidocain injectionGroup 1: Kinesiotherapy Group 2: Dry needling Group 3: lidocain injection | Other | Group 1 |
Primary outcome
Visual Analog Scala (VAS)
Time frame: All patients were evaluated with VAS and SF-36 form before and 3 weeks after treatment.
The VAS scale is a pain scale with marked 0-10 areas. Zero represents the absence of pain, while 10 represents very severe pain.
Short form-36 (SF-36)
Time frame: All patients were evaluated with VAS and SF-36 form before and 3 weeks after treatment.
The SF-36 form consists of 36 items to evaluate the daily life activities of the patients. It is used to evaluate many daily life functions such as general health status, physical condition, social status, emotional state. A high SF-36 score is one of the indicators of well-being in health.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Aug 2023.
- Background: PubMed 30883331Dogan N, Sengul I, Akcay-Yalbuzdag S, Kaya T. Kinesio taping versus dry needling in the treatment of myofascial pain of the upper trapezius muscle: A randomized, single blind (evaluator), prospective study. J Back Musculoskelet Rehabil. 2019;32(5):819-827. doi: 10.3233/BMR-181162.
- Background: PubMed 28343625Ay S, Konak HE, Evcik D, Kibar S. The effectiveness of Kinesio Taping on pain and disability in cervical myofascial pain syndrome. Rev Bras Reumatol Engl Ed. 2017 Mar-Apr;57(2):93-99. doi: 10.1016/j.rbre.2016.03.012. Epub 2016 May 10. English, Portuguese.
- Background: PubMed 33132718Albagieh H, Aloyouny A, Alshehri N, Alsammahi N, Almutrafi D, Hadlaq E. Efficacy of lidocaine versus mepivacaine in the management of myofascial pain. Saudi Pharm J. 2020 Oct;28(10):1238-1242. doi: 10.1016/j.jsps.2020.08.014. Epub 2020 Aug 28.
- Background: PubMed 29988746Raeissadat SA, Rayegani SM, Sadeghi F, Rahimi-Dehgolan S. Comparison of ozone and lidocaine injection efficacy vs dry needling in myofascial pain syndrome patients. J Pain Res. 2018 Jun 29;11:1273-1279. doi: 10.2147/JPR.S164629. eCollection 2018.
- Background: PubMed 20823359Kalichman L, Vulfsons S. Dry needling in the management of musculoskeletal pain. J Am Board Fam Med. 2010 Sep-Oct;23(5):640-6. doi: 10.3122/jabfm.2010.05.090296.
- Background: PubMed 25661462Gerber LH, Shah J, Rosenberger W, Armstrong K, Turo D, Otto P, Heimur J, Thaker N, Sikdar S. Dry Needling Alters Trigger Points in the Upper Trapezius Muscle and Reduces Pain in Subjects With Chronic Myofascial Pain. PM R. 2015 Jul;7(7):711-718. doi: 10.1016/j.pmrj.2015.01.020. Epub 2015 Feb 4.
- Background: PubMed 32944559Ghasemi M, Mosaffa F, Hoseini B, Behnaz F. Comparison of the Effect of Bicarbonate, Hyaluronidase, and Lidocaine Injection on Myofascial Pain Syndrome. Anesth Pain Med. 2020 Jun 23;10(3):e101037. doi: 10.5812/aapm.101037. eCollection 2020 Jun.
- Background: PubMed 27475508Fricton J. Myofascial Pain: Mechanisms to Management. Oral Maxillofac Surg Clin North Am. 2016 Aug;28(3):289-311. doi: 10.1016/j.coms.2016.03.010.
- Background: PubMed 25724849Shah JP, Thaker N, Heimur J, Aredo JV, Sikdar S, Gerber L. Myofascial Trigger Points Then and Now: A Historical and Scientific Perspective. PM R. 2015 Jul;7(7):746-761. doi: 10.1016/j.pmrj.2015.01.024. Epub 2015 Feb 24.
- Background: PubMed 20149248Fleckenstein J, Zaps D, Ruger LJ, Lehmeyer L, Freiberg F, Lang PM, Irnich D. Discrepancy between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: results of a cross-sectional, nationwide survey. BMC Musculoskelet Disord. 2010 Feb 11;11:32. doi: 10.1186/1471-2474-11-32.
- Background: PubMed 31775405Onat SS, Polat CS, Bicer S, Sahin Z, Tasoglu O. Effect of Dry Needling Injection and Kinesiotaping on Pain and Quality of Life in Patients with Mechanical Neck Pain. Pain Physician. 2019 Nov;22(6):583-589.
- Background: PubMed 27190430Ozturk G, Kulcu DG, Mesci N, Silte AD, Aydog E. Efficacy of kinesio tape application on pain and muscle strength in patients with myofascial pain syndrome: a placebo-controlled trial. J Phys Ther Sci. 2016 Apr;28(4):1074-9. doi: 10.1589/jpts.28.1074. Epub 2016 Apr 28.
- Individual participant dataSharing planned: Undecided
Related trials for Myofascial Pain Syndrome
Active, not recruiting
Objective Measurement of Pain Regulation in Individuals Who Have Received Internet-delivered Exposure-based Cognitive Behavior Therapy
Fibromyalgia
Not yet recruiting
Effects of IASTM, Deep Friction Massage, and Sham Instrument-Assisted Soft Tissue Mobilization on Electromyographical Activation, Pain and Function in Non-Specific Low Back Pain
Low Back Pain, Trigger Point Pain, Myofascial
Enrolling by invitationPhase 3
Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
Fibromyalgia
Recruiting
Exercise Interventions and Dietary Advice in Fibromyalgia and IBS
Fibromyalgia, Irritable Bowel Syndrome
Recruiting
Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study
ME/CFS, Fibromyalgia (FM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Seher Kara, MD study director
Gaziosmapaşa Training and Research Hospital
Questions about this trial
What is this clinical trial studying?
An observational study of Myofascial Pain Syndrome, run by Bursa City Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Visual Analog Scala (VAS) (time frame: All patients were evaluated with VAS and SF-36 form before and 3 weeks after treatment.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06018675, which also lists 14 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2023.